Steven K Burke Selected Research

calcium phosphate

11/2003	Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
9/2002	The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven K Burke Research Topics

Disease

9	Chronic Renal Insufficiency 07/2023 - 10/2003
8	Hyperphosphatemia 01/2022 - 04/2003
7	Arteriovenous Fistula 03/2022 - 04/2013
5	Fistula 01/2023 - 08/2014
5	Vascular Calcification 05/2005 - 02/2002
5	Chronic Kidney Failure (Chronic Renal Failure) 11/2003 - 02/2002
4	Renal Insufficiency (Renal Failure) 07/2023 - 08/2003
3	Anemia 07/2023 - 01/2022
3	Myocardial Infarction 07/2023 - 02/2002
3	Kidney Diseases (Kidney Disease) 01/2023 - 01/2008
3	Secondary Hyperparathyroidism 05/2005 - 09/2002
3	Hypercalcemia (Milk Alkali Syndrome) 09/2004 - 07/2002
2	Stroke (Strokes) 07/2023 - 07/2023
2	Hypoxia (Hypoxemia) 07/2023 - 01/2022
2	Peripheral Arterial Disease 04/2016 - 12/2014
2	Fibrosis (Cirrhosis) 08/2003 - 09/2002
1	Heart Failure 07/2023
1	Thrombosis (Thrombus) 07/2023
1	Pathologic Constriction (Stenosis) 08/2014
1	alpha 1-Antitrypsin Deficiency (alpha 1 Antitrypsin Deficiency) 01/2012
1	Hyperparathyroidism 01/2008
1	Arteriosclerosis 01/2008
1	Bone Diseases (Bone Disease) 09/2004
1	Proteinuria 11/2003
1	Nephrocalcinosis 11/2003
1	Uremia 11/2003
1	Vascular Diseases (Vascular Disease) 09/2003
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 08/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2003
1	Hyperplasia 09/2002
1	Aortic Aneurysm (Aneurysm, Aortic) 02/2002
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2002

Drug/Important Bio-Agent (IBA)

12	Sevelamer (RenaGel)FDA Link 12/2008 - 07/2002
11	Phosphates (Orthophosphate)IBA 01/2022 - 07/2002
8	cholesterol-binding proteinIBA 03/2022 - 01/2012
8	Phosphorus (Red Phosphorus)IBA 01/2008 - 09/2002
8	CalciumIBA 05/2005 - 02/2002
7	Pancreatic Elastase (Elastase)IBA 03/2022 - 01/2012
3	vadadustatIBA 07/2023 - 01/2022
3	MineralsIBA 12/2008 - 02/2002
3	Calcium Carbonate (Limestone)FDA Link 11/2003 - 09/2002
2	Prolyl-Hydroxylase InhibitorsIBA 07/2023 - 01/2022
2	Darbepoetin alfa (Aranesp)FDA Link 07/2023 - 07/2023
2	HematinicsIBA 07/2023 - 07/2023
2	omega-Chloroacetophenone (Mace)IBA 07/2023 - 07/2023
2	SolutionsIBA 03/2022 - 01/2019
2	SaltsIBA 05/2005 - 09/2003
2	LipidsIBA 06/2004 - 04/2003
2	calcium phosphateIBA 11/2003 - 09/2002
1	IronIBA 01/2022
1	ElastinIBA 01/2016
1	Phenobarbital (Luminal)FDA Link 12/2014
1	Dihydrotachysterol (AT 10)IBA 08/2014
1	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 01/2012
1	Vitamin D FDA LinkGeneric 01/2008
1	Dosage Forms (Dosage Form)IBA 07/2006
1	PolymersIBA 05/2005
1	CreatinineIBA 11/2003
1	AlbuminsIBA 09/2003
1	calcium acetate (Phoslo)FDA LinkGeneric 09/2003
1	Adenine FDA LinkGeneric 08/2003

Therapy/Procedure

12	Renal Dialysis (Hemodialysis) 01/2023 - 02/2002
1	Surgical Amputation (Amputations) 04/2016
1	Therapeutics 01/2012
1	Renal Replacement Therapy (Therapies, Renal Replacement) 09/2006